Neurovaccinia virus propagated in the presence of bromodeoxyuridine loses the capacity to produce necrosis in the skin of rabbits. Mechanisms underlying this loss were studied. The population under study consisted predominantly of virus particles capable of producing necrosis (RS +) and a small portion of particles which had lost this capacity (RS-). An RS-clone isolated from the population induced an inhibitor of interferon type in rabbit skin, which markedly inhibited reproduction of RS + virus strains and consequently the capacity of these strains to produce necrosis.
INTRODUCTION
The capacity of some viruses of the variola-vaccinia subgroup to produce necrosis upon intracutaneous inoculation of rabbits has been described by Fenner (I958) and Ghendon & Chernos 0964) .
In the course of passages in L-cell cultures TK-strain (Kit et al. I963) of neurovaccinia virus in the presence of 5-bromodeoxyuridine we obtained a variant (RS-) which had completely lost the capacity to produce dermal necrosis in rabbits (Ghendon, Chernos & Rozina, t967) . Similar results were obtained by Ferrari et al. 0965) with vaccinia virus passaged in the presence of iododeoxyuridine.
In the clonal analysis of our RS-variant of vaccinia virus, of I6 clones under study only one (M-156) lost the capacity to produce dermal necrosis in rabbits, while the other ~ 5 clones were definitely RS + (Chernos & Apridonidze, I968) . Nevertheless, the whole population from which these clones had been isolated produced no necrosis by the intracutaneous route in rabbits. Thus, this property was determined not by the virus particles prevailing in the population but by those infective particles which were much less numerous.
We report here an investigation of the mechanism of this phenomenon.
METHODS

Viruses.
A neuropathogenic variant of vaccinia virus, MM strain, and rabbit pox virus, UTRECHT strain, were used which produced necrosis when inoculated intracutaneously in rabbits (RS + marker), as well as a variant of the MM strain which had undergone 20 consecutive passages in L-cell cultures (TK-) in the presence of 25 #g./ml. 5-bromodeoxyuridine and had lost its capacity to produce necrosis (RS-). The virus pools were prepared from chorioallantoic membranes of chick embryos inoculated according to the method of Westwood, Phipps & Boulter (I957) . Western equine encephalitis virus was passaged in chick embryo fibroblast tissue culture.
Cell cultures. Primary cultures of chick embryo fibroblasts prepared by trypsinization were used for virus assay. The virus concentration was determined by counting plaques under the agar overlay described by Porterfield & Allison (196o) .
Animals. Albino chinchilla rabbits weighing 2 to 2. 5 kg. were used.
RESULTS
For interpretation of the clonal analysis of the RS-population of neurovaccinia virus we assumed that mutant particles composing it, in particular the M-I56 RS-variant, possessed a higher interfering activity and inhibited multiplication in the skin of rabbits of highly pathogenic RS + virus which produced necrosis. To test this assumption experimentally, tests were made in which the M-I56 mutant was mixed with neurovaccinia virus, rabbit pox virus or RS + M-I55 clone recovered from an RS-population ofneurovaccinia virus. The resulting mixture was inoculated intracutaneously in rabbits. Tenfold dilutions of neurovaccinia, rabbit pox or M-I55 clone viruses were mixed I : I so that the mixture contained the number of p.f.u, indicated in Table I of RS ÷ virus strain and Io 6 p.f.u, of M-~56 mutant in o.z ml. In controls, RS + strains were mixed instead of the mutant with an equal amount of medium I99. The mixture was inoculated intracutaneously in o.e ml. doses in two rabbits, and the results were read at 5 days. M-I56 clone in control produced no necrosis by the intracutaneous route using lo 6 p.f.u. Neurovaccinia and rabbit pox viruses produced necrosis after intracutaneous inoculation of lOO p.f.u, or more (Table I) . At the same time Ioo or even moo p.f.u, of neurovaccinia or rabbit pox virus mixed with Io 6 p.f.u, of M-I56 mutant failed to produce necrosis. However, when the dose of RS + viruses in mixture was increased from Io 4 to 1o 5 p.f.u., addition of M-I56 mutant did not prevent the development of necrosis. Thus the M-I56 mutant was capable of preventing necrosis produced by RS + strains at a ratio of p.f.u, of the mutant to p.f.u, of RS + virus moo: 1, that is, under conditions in which the number of infective particles of M-~56 mutant was Iooo-fold greater than that of RS + particles of 'wild' virus type.
On the other hand, in experiments with RS + M-I55 clone isolated from the same virus population from which RS-M-I56 clone had been obtained, the latter prevented necrosis produced by RS + M-I55 clone when the number of virus particles of RS + clones was IOOOfold greater than that of RS-particles. We suggest, therefore, that the inability of our RSpopulation of neurovaccinia virus to produce dermal necrosis in rabbits was indeed due to the small number of RS-virus particles present in the population.
We were interested to find out whether reproduction of M-I56 mutant was necessary for manifestation of its above-mentioned inhibiting activity and whether this mutant could change the capacity of RS + viruses to produce necrosis or inhibit multiplication of wild virus in the skin of rabbits. Rabbits were inoculated intracutaneously with Io 3 p.f.u, of neurovaccinia virus, Io 6 p.f.u, of M-156 mutant, and a mixture containing Io 3 p.f.u, of neurovaccinia virus and Io 6 of M-I56 mutant in active or inactivated form. Inactivation was achieved by ultraviolet irradiation 0o,ooo erg/mm 2 with the thickness of the viruscontaining fluid layer [ mm.). At 72 hr in one group of rabbits areas of the skin into which the virus had been inoculated were cut out and I g. of skin was minced in 2 ml. of medium 199 in a homogenizer of ultraturrax type. Since neurovaccinia virus produced plaques in chick embryo fibroblast tissue culture at 4 °0 and M-156 clone had lost this capacity, titration was done at 4 °o in determinations of the titre of RS + virus in areas of the skin infected with a mixture of viruses or only RS + virus. In the other group of rabbits development of necrosis was observed. Neurovaccinia virus multiplied well in the skin of rabbits while M-156 mutant did so very poorly. When rabbits were inoculated with a mixture of neurovaccinia virus and either infective or inactivated M-I56 mutant, reproduction of the RS + strain was almost completely inhibited (Table 2) . At the same time development of necrosis in rabbit skin was also inhibited. This evidence thus demonstrated that the capacity of M-I56 mutant to prevent necrosis by RS + virus strains was due to marked inhibition of RS + strain multiplication, multiplication of RS-mutant being not necessary for manifestation of this inhibiting activity. 
6xIo ~ o
We assumed, on the basis of the results obtained, that the inhibiting capacity of the M-I56 variant was due to induction by this virus of an inhibitor of interferon type. To test this assumption experiments were made in which extracts were prepared of rabbit skin infected with M-156 variant or wild virus. Rabbit skin was inoculated with [on p.f.u, of RS + strain of neurovaccinia virus or the same dose of M-I56 variant in the active or u.v.-inactivated form. At 24 hr the area of the skin was cut out, minced in Io ml. of medium ~99 in a homogenizer of ultraturrax type, clarified at 3ooo rev./min, and freed from virus particles in MSE Superspeed ultracentrifuge at 6o,ooog for I hr (rotor 24Io ). The supernatant fluid was heated at 55 ° for x hr and used in the experiment. In some experiments the extract instead of being heated was incubated at pH 2"5 for the inactivation of the virus. The absence of the infective virus in extracts was checked by inoculation of chick embryo tissue culture or chorioallantoic membrane of 1a-day-old chick embryo. Neurovaccinia virus, MM strain, and rabbit pox virus were mixed with the heated extract at a ratio of I : I so that o.2 ml. contained Io 4 p.f.u, of rabbit pox virus or Io 4 p.f.u, of neurovaccinia virus. In controls, the active virus was mixed with medium 199. The mixture was inoculated intracutaneously in rabbits.
M-156 mutant, both in active form and after inactivation by u.v. induced in rabbit skin formation of a substrate capable of preventing necrosis produced by neurovaccinia or rabbit pox virus (Table 3) . At the same time an extract of skin infected with neurovaccinia virus was unable to prevent necrosis when mixed with active neurovaccinia virus.
The inhibiting effect of rabbit skin extract against neurovaccinia and Western equine encephalitis viruses was manifested only in a homologous system and not in a heterologous system (Table 4 )-The extract potency was not diminished after treatment at pH 2"5 and 4 ° overnight. Infected rabbit skin extract was diluted with medium I99 I:4 and added to the cell culture. After 24 hr contact the cells were washed with Hanks's balanced salt solution and infected with neurovaccinia virus at multiplicity of io p.f.u./cell or Western equine encephalitis virus at multiplicity 3 to 5 p.f.u./cell. After I hr adsorption period at 24 ° the cells were washed to remove unadsorbed virus and incubated at 360 for 24 hr. Virus yield was measured by titration in chick embryo fibroblast cell culture. The results indicate that there is a strong inhibition in homologous system only. 4 5"0 x io ~ 3"5 x io 5 93 8"7 x io 5 7"0 x io 4 92
DISCUSSION
The results obtained are of interest first of all from the point of view of investigation of genetic characters of virus populations. Properties of virus populations are usually determined by the properties of the dominant type of virus particles. The appearance in our virus populations of even a few mutants with increased interfering activity radically changed the capacity of the population to produce necrosis by intracutaneous inoculation of rabbits despite the fact that the number of RS + particles in the population was many times greater than that of RS-particles. Hence it follows that the properties of virus population are not always determined by the properties of dominating virus particles.
Vaccinia virus is able to induce interferon production in the skin of rabbits (Nagano & Kojima, I958; Nagano, I967) . On the basis of our studies ( Table 3 ) we suggest that the RS-clone M-I56 induced in rabbit skin production of a sufficient amount of an inhibitor of interferon type in contrast to RS + strains of vaccinia virus. When rabbits are inoculated intracutaneously with a mixture of M-156 mutant and RS + virus multiplication of the latter and consequently production of necrosis is inhibited by interferon-like inhibitor induced by M-I56 clone.
The capacity of RS-M-I56 clone to prevent necrosis by RS + virus strains varied considerably with different viruses. Thus multiplication of neurovaccinia or rabbit pox virus was inhibited at an RS-clone to RS + strain ratio of iooo: I. At the same time manifestation of skin pathogenicity of RS + clone M-I55 isolated from the RS-population of neurovaccinia virus was inhibited by clone M-I56 even when the number of p.f.u, of the RS + clone was Ioo-fold greater. It should be mentioned that the necrosis-producing capacity of all the strains studied was closely similar; necroses were produced by IOO to IOOO p.f.u, of virus. Thus, varying inhibiting activity of M-156 variant with regard to different RS-viruses appears to be explained by diverse sensitivity of these viruses to an interferon-like inhibitor. It may also be suggested that RS + viruses under study had varying capacities of active inhibition of the effect of interferon, as has been demonstrated for some viruses of variolavaccinia subgroup (Ghendon, I965; Bektemirov & Gumennik, I967) .
The results show that the inhibitor has similar properties to interferon. Investigation of mutants of vaccinia virus possessing increased interferon-stimulating activity may be of interest from the point of view of search for a highly active interferon stimulator capable of inhibiting multiplication of a virulent virus in the organism. The use for this purpose of non-pathogenic virus mutants has a certain advantage since such viruses will induce not only interferon production but subsequently also the specific antibody response.
